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Family history is a major determinant of
subclinical peripheral arterial disease in young
adults
R. James Valentine, MD,a Rudy Guerra, PhD,c Phillip Stephan, MD,a Eva Scoggins, RVT,a G. Patrick
Clagett, MD,a and Jonathan Cohen, PhD,b Dallas and Houston, Tex
Background: Cardiovascular disease is prevalent in first-degree relatives of young adults with premature-onset peripheral
arterial occlusive disease (premature PAD), but it is not known whether the genetic influence is independent of other risk
factors, the most prevalent of which is smoking. This study was performed to determine the relative contributions of
family history and smoking to the development of occult PAD in siblings of patients with premature PAD.
Methods: The prevalence of occult PAD was determined with carotid, abdominal, and lower extremity duplex ultrasound
scanning in 50 asymptomatic siblings (25 men, 25 women) of patients with premature PAD (onset<49 years). Thirty of
the siblings (60%) were active smokers, and 20 had never smoked. Age-matched and sex-matched reference groups
included 50 asymptomatic heavy smokers (>20 cigarettes/day) and 50 nonsmokers.
Results: Duplex ultrasound scans demonstrated raised arterial lesions in 20 asymptomatic siblings (40%), 20 heavy
smokers (40%), and 2 nonsmoking control subjects (4%), resulting in 42 affected and 108 unaffected subjects. As
expected, smokers were far more likely to have arterial lesions than were nonsmokers (odds ratio [OR], 11.19; 95%
confidence interval [CI], 4.1-30.7; P < .0001). Individuals with a family history of premature PAD were almost three
times more likely to have arterial lesions than those with no family history of cardiovascular disease (OR, 2.76; 95% CI,
1.3-5.8; P  .006). Stratified and multivariable logistic regression indicated no interaction between smoking and family
history, indicating simple additive effects on PAD.
Conclusions: Family history is a major determinant of occult PAD in young adults, and is at least as important as standard
atherosclerotic risk factors. A high proportion of heavy smokers have clearly detectable lesions even though asymptom-
atic. Smoking and family history act additively to increase the risk for premature PAD. (J Vasc Surg 2004;39:351-6.)
The onset of atherosclerotic peripheral arterial disease
before the age of 50 years (premature PAD) is associated
with a remarkably poor prognosis. Affected patients have
high rates of disease progression, bypass graft failure, major
limb amputation, and early death.1-4 Premature PAD is
relatively rare in young adults, and, it is presumed, reflects
the greatly accelerated development of atherosclerosis in
affected individuals. Therefore the etiologic factors respon-
sible for atherosclerosis are likely to be more pronounced,
and consequently more readily identifiable, in patients with
rapidly progressive PAD.
A number of risk factors for premature PAD have been
demonstrated, including cigarette smoking, hyperlipid-
emia, hyperhomocysteinemia, hypercoagulable states, and
elevated levels of lipoprotein(a).5-8 However, no single
clinical condition has been shown to explain the rapid
development of atherosclerosis in most patients.9 There-
fore premature PAD must represent the joint effects of a
variety of environmental and genetic factors.
In a previous study we found that symptomatic cardio-
vascular disease is highly prevalent in first-degree relatives
of patients with premature PAD.10 The prevalence of pre-
mature vascular events was far higher in siblings of patients
with premature PAD (24%) than in siblings of healthy,
age-matched control subjects (7%) or in siblings of patients
with premature coronary artery disease (14%). Further-
more, occult vascular disease was identified in half of a small
cohort of asymptomatic siblings studied with duplex ultra-
sound scanning. However, two thirds of the asymptomatic
siblings had a history of smoking, and the study design did
not allow us to determine the relative roles of smoking and
inheritance on development of premature PAD. The
present study was undertaken to test the hypothesis that
family history exerts a strong independent influence on the
development of peripheral atherosclerosis in young adults.
SUBJECTS AND METHODS
The study was approved by the Institutional Review
Board of the University of Texas Southwestern Medical
Center.
Study subjects. The families of 100 nondiabetic men
and women with symptoms of lower extremity atheroscle-
rotic occlusive disease beginning at age 49 years or
younger, were evaluated to identify asymptomatic siblings
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for lower extremity arterial studies. Eligible siblings were
identified from detailed family histories of the probands,
and a detailed medical history was obtained, including the
presence of overt coronary artery disease (CAD; angina,
previous myocardial infarction, previous coronary revascu-
larization), cerebrovascular disease (transient ischemic at-
tack, stroke, previous carotid endarterectomy), or PAD
(intermittent claudication, rest pain, previous revasculariza-
tion, ischemic amputation). Exclusion criteria included age
greater than 55 years, history of diabetes mellitus, or pres-
ence of overt vascular disease. To remove the potentially
confounding influence of remote smoking, we included
only those siblings who were active smokers or who had
never smoked.
Asymptomatic siblings who met eligibility criteria were
identified from a total of 31 of the original 100 families.
Fourteen of the 31 probands (45%) originally came to our
institution with claudication, 15 had rest pain (48%), and 2
had tissue loss (7%). The other 69 families did not meet
eligibility criteria for a number of reasons: in 27 families
there were no living, asymptomatic siblings younger than
56 years; in 31 families all asymptomatic siblings lived in
other states and could not travel to join the study; in 3
families asymptomatic siblings were estranged and could
not be contacted; and in 8 families siblings refused to join
the study. All living siblings in the remaining 31 families
were screened, and the first 50 asymptomatic siblings to
meet eligibility criteria were included in the study. These 50
siblings were selected independent of smoking status.
After informed consent was obtained, data regarding
demographics and the presence of atherosclerotic risk fac-
tors (history of smoking, hypertension, hyperlipidemia)
were recorded. Each participating subject was then invited
to the vascular laboratory for lower extremity vascular
ultrasound examination and determination of fasting
plasma lipid concentrations.
References populations. Two independent groups of
individuals were used as reference groups for the asymp-
tomatic siblings of patients with PAD. Both groups were
matched for age and sex with the study group subjects. One
group included 50 asymptomatic men and women who had
smoked the equivalent of at least one pack of cigarettes per
day for 20 years and were active smokers at the time of entry
into the study. These individuals were recruited from the
community, and none had symptoms of overt coronary
disease, cerebral disease, or PAD. A second group consisted
of 50 healthy men and women who never smoked. These
subjects were also recruited from the community, and many
were employees of the medical center. Detailed family
histories were obtained with personal interviews with each
subject. All vascular events in first-degree family relatives
were recorded, including previous myocardial infarction,
stroke, intermittent claudication, and revascularization
procedures of the heart (coronary artery bypass grafting,
percutaneous transluminal angioplasty), carotid artery, or
lower extremities. The age at onset of the vascular event was
noted for each individual. Vascular events occurring at age
55 or younger were defined as premature, in keeping with
the criteria of the National Cholesterol Education
Program.11
Duplex ultrasound scanning. Study subjects and
control subjects underwent arterial imaging with duplex
ultrasound scanning (Acuson 128XP; Siemens Co, Moun-
tain View, Calif) to detect early, asymptomatic disease
(occult disease) in the carotid and lower extremity circula-
tions. All duplex scanning was performed by a single regis-
tered vascular technologist in a vascular laboratory accred-
ited by the Intersocietal Commission for the Accreditation
of Vascular Laboratories. A 5-MHz probe was used to
visualize the entire luminal surface of the extracranial ca-
rotid artery (common, internal, and external carotid seg-
ments) and the lower extremity arteries (aorta, common





subjects (n  50)
Nonsmoking control
subjects (n  50) P
Mean age (y) 48  5 47  4 46  4 .11
Arterial plaques 20 (40) 20 (40) 2 (4) .001
Male gender 25 (50) 24 (48) 26 (52) .92
White race 45 (90) 48 (96) 46 (92) .50
Family history 50 (100) 8 (16) 8 (16) NA*
Smoking 30 (60) 50 (100) 0 NA*
Hypertension 8 (16) 1 (2) 9 (18) .08
Total cholesterol
(mg/dL)
188  46 197  39 190  32 .52
Serum triglycerides
(mg/dL)
173  104 152  90 122  77 .02
HDL-C (mg/dL) 46  18 44  14 53  24 .04
LDL-C (mg/dL) 114  38 126  34 118  31 .19
Values represent mean  SEM, or number with percent in parentheses.
HDL-C, Plasma high-density lipoprotein concentration; LDL-C, Plasma low-density lipoprotein concentration; NA, not available.
*Values were selection criteria.
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iliac, external iliac, common femoral, superficial femoral,
and popliteal segments). Arterial plaque disease was defined
as a focal area of luminal encroachment with mixed echoes
or a calcified area with an irregular surface. Plaques were
quantified by calculating the degree of luminal encroach-
ment, and expressed as a percentage of luminal narrowing,
according to standardized criteria.12 An assessment of he-
modynamic significance was determined for each plaque,
with flow velocity criteria.13
Assay of plasma lipids and lipoproteins. Fasting
plasma lipids and high-density lipoprotein cholesterol
(HDL-C) concentrations were assayed in the 150 study
participants after overnight fasting. As reported in our
previous study,10 plasma cholesterol and triglyceride con-
centrations were determined in duplicate using enzymatic
assay with commercial reagents (Cholesterol/HP; Boehr-
inger Mannheim, Indianapolis, Ind; triglycerides/GPO-
TRINDER; Sigma Diagnostics, St Louis, Mo). Apoli-
poprotein B–containing lipoproteins were precipitated
with sodium phosphotungstate (0.555 mmol/L), and the
HDL-C concentration was measured in the supernatant.
Intra-assay variation was less than 5%.
Statistical analysis. Univariate comparisons between
affected and unaffected subjects were performed with t tests
for continuous variables and 2 tests for categorical vari-
ables. Crude odds ratios (OR) for sonographically detected
arterial disease were calculated separately for smoking and
family history of PAD. P values and 95% confidence inter-
vals (CI) for odds ratios were based on the Woolf method,
whereby Gaussian-based intervals for log(OR) are first cal-
culated and then backtransformed14 to the original OR
scale. To assess modifying effects (interaction) of smoking
on the association between PAD and family history of PAD
we used the Mantel-Haenszel 2 test statistic, with smoking
status as the stratifying variable. Because of the small cell
counts in some of the tables, it was necessary to evaluate the
validity of the asymptomatic 2 (df  1) distribution14,15;
in each application of the Mantel-Haenszel test the four
sums of expected cell frequencies across tables satisfied the
Mantel and Fleiss criterion15 for valid use of the Mantel-
Haenszel test. For comparison, we also applied the Woolf
test of interaction.14,15 The stratified analysis of the associ-
ation between PAD and family history, given smoking
status, is a direct approach with relatively few assumptions.
To simultaneously examine confounding or interaction of
several covariates, logistic regression analysis was per-
formed. Coefficient estimates were assessed with corre-
sponding t statistics and analysis of deviance.16
RESULTS
Characteristics of asymptomatic siblings, smoking con-
trol subjects, and nonsmoking control subjects are shown
in Table I. Thirty of 50 asymptomatic siblings (60%) were
active smokers, and the other 20 (40%) had never smoked.
Eight control subjects who smoked (16%) had at least one
first-degree relative with premature vascular disease, as did
8 (16%) of the nonsmoking control subjects. Comparison
of the asymptomatic siblings with the smoking and non-
smoking control subjects demonstrated no significant dif-
ferences in mean age, race, or prevalence of hypertension.
Duplex ultrasound scans depicted lower extremity ar-
terial lesions in 20 asymptomatic siblings (40%), 20 smok-
ing control subjects (40%), and 2 nonsmoking control
subjects (4%). The distribution of lesions is shown in Table
II. All lesions in affected subjects from the two reference
groups were associated with luminal encroachment of less
than 20% diameter loss. More advanced stenoses were
detected in 7 siblings of patients with PAD (30%-49% in 4,
50% in 3). Most affected subjects had lesions in one
artery; multiple arteries were involved in 7 siblings (14%)
and in 7 smoking control subjects (14%). Carotid lesions
were documented in 6 asymptomatic siblings (12%) and in
1 asymptomatic smoker (2%), each of whom also had lower
extremity involvement. None of the subjects had a carotid
lesion if the lower extremity duplex scan was normal. The
nature of lower extremity symptoms among the 31 original
probands had no correlation with the prevalence of arterial
lesions in the asymptomatic siblings: 8 (40%) of 20 siblings
of probands with claudication were affected, as were 10
(40%) of 25 siblings of probands with rest pain and 2 (40%)
of five siblings of probands with tissue loss.
Comparisons between the 42 subjects with arterial
lesions and the 108 subjects with normal duplex scans are
shown in Table III. Affected patients had a higher preva-
Table II. Distribution of arterial lesions and degree of
luminal narrowing detected with duplex ultrasound











1-19 5 5 0
20-49 1 0 0
50 1 0 0
Total 7 5 0
Aorta (%)
1-19 7 6 0
20-49 1 0 0
50 0 0 0
Total 8 6 0
Iliac (%)
1-19 8 9 0
20-49 1 0 0
50 0 0 0
Total 9 9 0
Femoral (%)
1-19 11 13 2
20-49 1 0 0
50 1 0 0
Total 13 13 2
Popliteal (%)
1-19 3 4 0
20-49 0 0 0
50 1 0 0
Total 4 4 0
*There was no statistical difference in the total number of lesions at each
level between asymptomatic siblings and smoking control subjects.
JOURNAL OF VASCULAR SURGERY
Volume 39, Number 2 Valentine et al 353
lence of smoking (88% vs 40%; P .001) and family history
of premature vascular disease (62% vs 37%; P  .01).
Affected patients also had significantly higher levels of
triglycerides and lower levels of HDL-C; no statistical
differences were detected in age, race, sex, hypertension,
total cholesterol, and low-density lipoprotein cholesterol.
The odds of PAD was higher in smokers than nonsmokers
(OR, 11.19; 95% CI, 4.1-30.7; P  .0001), as well as in
patients with a family history (OR, 2.76; 95% CI, 1.3-5.8; P
 .006). Having both smoking and family history present
conferred an additive effect (Fig). The Mantel-Haenszel
test for interaction between smoking and family history was
inconclusive. The Woolf test for interaction, however,
clearly showed no significant interaction (P  .41), and
provided a common OR of 2.9 (95% CI, 1.2-6.6) between
smokers and nonsmokers, agreeing with the crude OR for
family history. Strictly additive effects between smoking
and family history were also demonstrated with logistic
regression (Table IV); associated ORs for smoking (OR,
11.5; P .05) and family history (OR, 2.9; P 0.05) again
agreed with crude ORs.
Multivariable logistic regression including smoking,
family history, HDL-C, and triglycerides showed no inter-
actions. Smoking, family history, and triglycerides were
statistically significant at the 5% level; HDL-C was not
significant. Estimated ORs for smoking (OR, 10.6) and
family history (OR, 2.6) in the presence of triglycerides
agreed with crude ORs, further demonstrating a lack of
synergism between the two variables.
DISCUSSION
The major findings of this study are that both smoking
and family history of cardiovascular disease are indepen-
dently associated with a significantly increased risk for
peripheral atherosclerosis in young adults. Although smok-
ing emerged as the dominant risk factor, direct measure-
ment of occult arterial disease revealed that the increased
risk associated with a positive family history is apparent even
in asymptomatic nonsmokers. This excess risk is not medi-
ated by other risk factors such as hypertension, diabetes, or
dyslipidemia. Occult arterial disease was also significantly
more common and more severe in heavy smokers with a
positive family history of premature PAD than in smokers
who did not have a family history of PAD (Fig). Taken
together, these data support the hypothesis that genetic
factors have an independent effect and exacerbate the ef-
fects of smoking on the development of atherosclerosis in
the peripheral vasculature.
Previous studies have demonstrated a correlation be-
tween a positive family history of vascular disease and
indirect markers of atherosclerosis such as carotid intima-
media thickness.17 In the present study we used duplex
ultrasound scanning to obtain direct, objective evidence of
occult arterial lesions in apparently healthy persons who did
not have symptoms of vascular disease. The data obtained
at duplex scanning revealed that premature PAD is even
more common among first-degree relatives of patients with
premature PAD than was apparent from clinical history.
Affected siblings had a predisposition for proximal arterial
involvement (Table II), similar to the distribution of arte-
rial lesions we identified in subjects with premature
PAD.1,8,9 In a previous study we found that 24% of first-
degree relatives (parents or siblings) of patients with pre-
mature PAD had a major vascular event before the age of 55
years. Our present data indicate that premature atheroscle-
rosis is also common even among first-degree relatives who
are still asymptomatic. Forty percent of asymptomatic sib-
lings of patients with premature PAD had raised atheroscle-
rotic plaques in the peripheral arteries before age 50 years.
The quantitative effect of heritability appears to be stronger
than many of the traditional risk factors for atherosclerosis,
Table IV. ANOVA table for logistic regression of arterial
disease on smoking and family history of premature
vascular disease
Source df Deviance P*
Smoking status 1 31.41 0




ANOVA, analysis of variance; df, degrees of freedom.
*2 P values for sequential analysis of deviance; P values depend on terms
previously included in model. Residual deviance is 139, with df  146.




(n  108) P
Mean age (y) 47  4 47  4 .30
Male gender 24 (57) 51 (47) .28
White race 40 (95) 99 (92) .45
Family history 26 (62) 40 (37) .01
Smoking 37 (88) 43 (40) .001
Hypertension 6 (14) 13 (12) .71
Total cholesterol (mg/dL) 195  41 190  41 .49
Serum triglycerides (mg/dL) 185  109 135  82 .003
HDL-C (mg/dL) 41  13 50  21 .007
LDL-C (mg/dL) 122  31 118  36 .52
Values represent mean  SEM, or number with percent in parentheses.
HDL-C, Plasma high-density lipoprotein concentration; LDL-C, plasma low density lipoprotein concentration.
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such as diabetes mellitus, hypertension, and hypercholes-
terolemia. Since the prevalence of other known risk factors,
such as lipoprotein(a), homocysteinemia, and hypercoagu-
lable states was not matched between groups, it is not
possible to determine whether the genetic effect observed
in this study is independent of these risk factors. However,
our previous study suggests that these factors have rela-
tively little influence on development of premature
PAD.9
Duplex scans also revealed a direct effect of heavy
smoking on peripheral atherosclerosis. Whereas raised le-
sions were virtually absent in nonsmokers who did not have
a family history of vascular disease, 40% of heavy smokers
had lesions in at least one artery. These data corroborate the
findings of others that showed that smoking is an important
risk factor for premature PAD. In the Pathologic Determi-
nants of Atherosclerosis in Youth Study, smoking was
associated with more extensive fatty streaks and raised
lesions in the abdominal aortic specimens of persons be-
tween 15 and 34 years of age who died of external causes.5
Smoking has also been associated with increased wall thick-
ening in the carotid and femoral arteries of asymptomatic
persons in the general population,18 and lower ankle-
brachial index and Doppler flow abnormalities in the fem-
oral artery in asymptomatic men.19 By documenting a high
proportion of heavy smokers with clearly detectable, raised
lesions in the peripheral arterial circulation, the present
study provides even more compelling evidence for a strong
association between smoking and early PAD. Thus our data
reiterate that smoking is the major risk factor for peripheral
atherosclerosis and that in a high proportion of heavy
smokers atherosclerosis will develop in the peripheral arter-
ies even in the absence of other risk factors such as
positive family history, diabetes, hypertension, or hyper-
lipidemia.
Consistent with our previous finding,10 elevated serum
triglyceride levels were positively associated with occult
disease in the present study. However, triglyceride levels
did not retain significance in the multivariate model. Any
relative quantitative effect was small, because it did not
influence ORs or statistical significance of smoking and
family history.
Despite the use of direct imaging and age-matched and
sex-matched control groups, the conclusions that can be
drawn from the present study are subject to a number of
limitations. First, we assume that the increased risk for
atherosclerosis associated with a positive family history is
conferred by genes, but the specific genes responsible have
not been identified. Therefore we cannot exclude the pos-
sibility that as yet unidentified environmental factors shared
by the family members in this study are in fact responsible
for the familial aggregation of atherosclerosis. We also
cannot exclude the possibility that the increased risk for
cardiovascular disease associated with family history may be
the result of siblings being exposed to a similar uterine
environment, as has been suggested by Barker.20
A second limitation of this study is that the ultrasound
technique used does not provide images of the coronary
circulation. Therefore our findings are limited to early
atherosclerosis in the lower extremity circulation. How-
ever, other studies have demonstrated that smoking and
family history are independent risk factors for occult
CAD,21,22 and we speculate that the presence of occult
CAD in the present study subjects would not have altered
our findings. Third, most subjects in this study were white.
Therefore the present findings may not be applicable to
other ethnic groups.
Although the results of the present study do not indi-
cate how the increased risk for atherosclerosis among rela-
tives of patients with premature PAD is mediated, our data
nevertheless have important clinical implications. The OR
of 2.7 for family history reflects the risk for occult arterial
disease in asymptomatic siblings of patients with premature
PAD, but does not take into account the symptomatic
siblings. Our previous study documented that 24% of sib-
lings experienced premature cardiovascular events.1 Taken
together, this means that approximately two thirds of the
siblings of patients with premature PAD have documented
arterial disease (24% symptomatic, 40% asymptomatic),
which suggests that there is a very large risk for cardiovas-
cular disease in families of patients with premature PAD.
Based on these findings, we recommend screening all sib-
lings of patients with premature PAD with detailed histo-
ries to detect symptomatic cardiovascular disease. Occult
lower extremity arterial disease may be readily identified in
asymptomatic siblings with duplex ultrasound scanning.
Symptomatic patients may benefit from medical treatment,
and asymptomatic siblings with occult disease would ap-
pear to be ideal candidates for intensive efforts at risk factor
modification, particularly avoidance of smoking.
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DISCUSSION
Dr Stuart I. Myers (Richmond, Va). Jim, that was really an
excellent tudy. And one of the questions that comes up in my mind
is, do you have any feeling at what age of onset this disease starts in
these patients, particularly the group you can identify with family
history and smoking?
Dr R. James Valentine. It is not clear that there is any
difference in the age of onset between patients who develop early
atherosclerosis and those who develop the disease later in life.
Atherosclerosis is thought to begin at about the age of 9. The
premature onset of symptoms before the age of 50 is assumed to
represent acceleration in the overall process. The current data
suggest that affected individuals may have been genetically predis-
posed to develop early atherosclerosis when exposed to external
risk factors, especially smoking.
Dr Daniel S. Rush (Johnson City, Tenn). Jim, this is another
thought-provoking paper. My question is that perhaps these pa-
tients are preconditioned, maybe even from infancy, because of
secondhand smoke. And I don’t know if your questioning of the
family histories identified that as a risk factor. But I’d also like for
you to speculate, perhaps, because it would seem that some of
these risk factors related to family history don’t really have identi-
fiable clinical manifestations.
Dr Valentine. We did not specifically determine whether any
of the subjects had been exposed to second-hand smoke during
childhood. Social habits such as smoking and dietary intake are
learned behaviors within families. Even if these individuals were
not physiologically preconditioned from second-hand smoke, they
probably psychologically preconditioned to smoke. Our data show
that a family history of cardiovascular disease is a clear risk factor for
premature PVD. However, it is not clear whether the risk is
transmitted through genes or through learned behavior during
childhood and adolescence. This is certainly a fertile area for
further study, especially genetic analyses.
Dr Alexander W. Clowes (Seattle, Wash). Jim, this is an
excellent and provacative study.
Can you tell us about the interaction between PAD and
coronary disease? Are they linked?
Dr Valentine. That’s a good question.
The variable that we examined was a history of cardiovascular
disease in a first-degree relative, regardless of location. Most of the
subjects with a positive family history had a relative with cardiac
disease, such as a documented myocardial infarction or coronary
bypass. Stroke and peripheral vascular disease were less prevalent
among the relatives of the controls. Many of the siblings with
premature PVD also had coronary disease. We were unable to
determine from this complex database whether having a relative
with atherosclerosis in one location was a stronger risk factor
compared with another location. Our data show that a family
history of premature atherosclerosis in any location is a risk factor
for premature PVD.
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